not losing weight on tirzepatide 2.5 tirzepatide? Here's what to do about it Tirzepatide Dosing - A Patient

Characterizing body composition modifying effects of a glucagon-like peptide 1 receptor-based agonist: A meta-analysis

GLP-1 RAs effectively reduce appetite and caloric intake, yet unstructured reduced dietary intake is often nutrient poor and patients risk losing the fiber, polyphenols, and foods that sustain microbiome diversity, normobiosis, microbial mediators, and intestinal barrier function

Decout A, Katz JD, Venkatraman S, Ablasser A

This phenomenon is directly correlated with increased leptin bioavailability in obese individuals, leading to heightened C-reactive protein binding to LEPR at multiple sites, thereby modifying the pleiotropic effects of leptin

What are the hypertensive disorders of pregnancy